Bioavailability and pharmacokinetic comparison between modified- and immediate-release formulations of tofacitinib in healthy volunteers.

Trial Profile

Bioavailability and pharmacokinetic comparison between modified- and immediate-release formulations of tofacitinib in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2015

At a glance

  • Drugs Tofacitinib (Primary) ; Tofacitinib
  • Indications Plaque psoriasis; Rheumatoid arthritis; Ulcerative colitis
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
    • 14 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top